Compare MESO & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MESO | IPAR |
|---|---|---|
| Founded | 2004 | 1982 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.6B |
| IPO Year | N/A | N/A |
| Metric | MESO | IPAR |
|---|---|---|
| Price | $17.07 | $101.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | N/A | ★ $125.50 |
| AVG Volume (30 Days) | 202.8K | ★ 213.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.18% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $633.98 | $3.49 |
| Revenue Next Year | $29.51 | $3.59 |
| P/E Ratio | ★ N/A | $19.66 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.61 | $77.21 |
| 52 Week High | $21.50 | $148.15 |
| Indicator | MESO | IPAR |
|---|---|---|
| Relative Strength Index (RSI) | 46.75 | 65.25 |
| Support Level | $16.50 | $98.38 |
| Resistance Level | $18.38 | $103.32 |
| Average True Range (ATR) | 0.58 | 2.93 |
| MACD | -0.02 | -0.17 |
| Stochastic Oscillator | 51.70 | 80.30 |
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations.. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.